Serum glycan signatures of gastric cancer. - Test2 - elhamkhani - TriplyDB

Serum glycan signatures of gastric cancer.

Serum glycan signatures of gastric cancer.

http://www.wikidata.org/entity/Q35064779

about

Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer Glucose metabolism in gastric cancer: The cutting-edge Emerging blood-based biomarkers for detection of gastric cancer Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass Spectrometry The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer Applications of Multiple Reaction Monitoring to Clinical Glycomics.Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases.Dietary Composition Influences Incidence of Helicobacter pylori-Induced Iron Deficiency Anemia and Gastric Ulceration.Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer.On-chip lectin microarray for glycoprofiling of different gastritis types and gastric cancer.Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer.Serum glycosylation characterization of osteonecrosis of the femoral head by mass spectrometry.Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery.Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC/MS and LC/MS/MS.Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma.Sample handling of gastric tissue and O-glycan alterations in paired gastric cancer and non-tumorigenic tissues.

P2860

Q26750872-E3C90CBF-C6AA-46CD-818A-8275A436B91B Q26766098-653A440F-6D7A-4452-ADFA-F849E8E8686D Q26778026-4E7DB5C3-BB99-496E-B709-800E5972D82A Q26778227-37381F7D-DAE3-43B3-AC54-D82AD41712A7 Q27024150-13F9E002-3ABB-4626-B17D-6FD22B2498C5 Q34092935-23FCC080-A98B-482F-AA75-5F775BE0951D Q34624649-03E344FC-D21F-4399-815A-72F4BEB4AB24 Q35065968-729D8DA9-60B5-498E-ACB3-AE19804AB64C Q35447868-E8522EB2-8650-4B83-AD1E-ADAF419BC089 Q36016305-1626D71E-8D5F-40FD-80AD-2FE2E8FFCF14 Q37424965-62E22B44-B0EF-4DE3-812F-7756DAB5DF30 Q37706879-C2F51F31-71F3-4D54-AE90-BFAA3943DFB8 Q40405625-9ACDED88-7491-4A7A-9CCA-B98AA01DF137 Q41396310-65153795-A6A0-4320-B060-3FB934298723 Q42124029-E5E99FE4-D75C-4A38-B384-868109671305 Q45298756-C72CFDD4-8890-48BE-A396-EEDE2256264C Q45999306-61EB6AF3-C1D4-431A-B82F-497050267401 Q47213195-B75AD33D-1ACF-42D9-A72C-690D78F06572 Q48251620-3490C519-D9FB-48C8-A155-2B61ADA7E1B3 Q49335113-9575E26D-CFB1-4955-8055-310F0E13D1FC Q49865262-ADE6E7DE-13DD-4E14-A106-9C9C1344B7E0

P2860

Serum glycan signatures of gastric cancer.

http://www.wikidata.org/entity/Q35064779

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Serum glycan signatures of gastric cancer.

@ast

Serum glycan signatures of gastric cancer.

@en

type

label

Serum glycan signatures of gastric cancer.

@ast

Serum glycan signatures of gastric cancer.

@en

prefLabel

Serum glycan signatures of gastric cancer.

@ast

Serum glycan signatures of gastric cancer.

@en

P1433

Q35064779-F0E2BE93-EA75-40DB-ACC3-47A2731ED9DB

P1476

Q35064779-2A4CD54A-0D8A-4A10-9388-31735677F71C

P2093

Q35064779-13E6C79B-1E8F-4341-ABCD-3EB03913BC0A

Q35064779-1A4DF832-8A00-49EE-B46C-8BE543098302

Q35064779-2E8A1AB7-5230-4B88-B894-5BFE1C0F8DAE

Q35064779-39CBDB30-9F35-4CDC-BEE7-EB398CEEEE85

Q35064779-4AB838D8-5FB1-465F-BD0C-7F2B9EF250E6

Q35064779-92D9306E-0DAA-4418-92D2-9C1375D6CC90

Q35064779-AA1D6A00-8CBC-47EC-8BA6-5C2B8183731D

Q35064779-AD4E2F84-953F-4938-8269-91A54883AE32

Q35064779-BD03B394-6034-4AB1-8F37-6E1FF5A14E01

Q35064779-D6953537-44F3-4FBF-8C79-20D79DE3D681

P2860

Q35064779-0ED9E4C4-D0FE-4B48-A8D4-450914DAD0EE

Q35064779-114730AD-2E34-49A5-A725-F0FEA9901892

Q35064779-13D86244-0B8A-4262-9E49-8318044CE159

Q35064779-147B4BEF-4F84-4C55-88F3-D4DCFF65F9D7

Q35064779-219BA4C2-9DEE-4E05-8D8E-E8EE5EF231B6

Q35064779-227AC86A-B5D3-4014-8B2B-42254E71F00A

Q35064779-25AEBCBE-588E-4A42-A21A-6F581050A576

Q35064779-27908B37-5BB7-41BD-855F-2C1B23A71447

Q35064779-28F77F40-C5C4-4336-BDF2-9F9FD2358C4E

Q35064779-2BC91610-DA19-4F96-A32C-59ABD3470366

P304

Q35064779-A5C3C152-5D13-415E-ABE9-FB105D17B355

P31

Q35064779-70149C23-36A5-4483-8DD1-747FE0B1ACB7

P356

Q35064779-B806AF9B-FE8A-4B41-9989-A9FDAA8CB0CA

P433

Q35064779-18CAA19E-C1EE-4B77-94B9-FDBC9C99677C

P478

Q35064779-09B18411-13AF-4838-BA36-7595C49F5FE8

P50

Q35064779-62D342E3-6841-4DA2-B282-D22E3C401A0C

Q35064779-CF8A6B0B-5ACD-47E0-B5C8-209EA3693AD7

P577

Q35064779-1A2EB249-7443-4350-8AE3-2641D41F223D

P698

Q35064779-CBE8E748-108A-46B7-8EA5-BC47F2FF8C8B

P932

Q35064779-FC4ADFF1-F713-4513-9C19-D1684CDB728A

P356

1940-6207.CAPR-13-0235

P1433

Cancer Prevention Research

P1476

Serum glycan signatures of gastric cancer

@en

P2093

Cara L Cooke

http://www.w3.org/2001/XMLSchema#string

Carlito B Lebrilla

http://www.w3.org/2001/XMLSchema#string

Cynthia C Williams

http://www.w3.org/2001/XMLSchema#string

David Rocke

http://www.w3.org/2001/XMLSchema#string

Donald A Barkauskas

http://www.w3.org/2001/XMLSchema#string

Jae Han Kim

http://www.w3.org/2001/XMLSchema#string

Javier Torres

http://www.w3.org/2001/XMLSchema#string

L Renee Ruhaak

http://www.w3.org/2001/XMLSchema#string

Lauren M Dimapasoc

http://www.w3.org/2001/XMLSchema#string

Margarita Camorlinga-Ponce

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Hallmarks of Cancer: The Next Generation

Helicobacter pylori infection induces gastric cancer in mongolian gerbils

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

Helicobacter pylori infection and the risk of gastric carcinoma

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

MALDI-FTMS characterization of oligosaccharides labeled with 9-aminofluorene.

High-mannose-type oligosaccharides from human placental arylsulfatase A are core fucosylated as confirmed by MALDI MS.

Alkaline degradation of oligosaccharides coupled with matrix-assisted laser desorption/ionization Fourier transform mass spectrometry: a method for sequencing oligosaccharides.

P304

226-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-13-0235

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24327722

http://www.w3.org/2001/XMLSchema#string

P932

3946197

http://www.w3.org/2001/XMLSchema#string